Official Title

Metabolic Response to Chardonnay Grape Marc Powder
  • Phase

    N/A
  • Study Type

    Interventional
  • Status

    Completed No Results Posted
  • Intervention/Treatment

    vitis vinifera ...
  • Study Participants

    31
To determine if the addition of chardonnay grape marc (also called pomace) powder enriched with grape seed extract to the diet will result in reducing blood levels of cholesterol or triglycerides.
Previous research on grape seed nutritional properties has predominantly been confined to grape seed extracts (GSE) containing only soluble components. In animal models, GSE has been shown to prevent increases in blood pressure, blood cholesterol, and insulin resistance. In humans, there have been improvements in blood pressure, however no significant effect on blood cholesterol levels. Whole milled grape marc flours deliver more dietary complexity than seed extracts alone. In addition to the extractable and non-extractable polyphenols, flour offers dietary fiber, minerals, sterols and polyunsaturated fats. Grape marc flour is currently used as a food ingredient that is incorporated into various baked goods. However, to obtain good control of the dose level, the product will be provided in capsule form for this study. For reference, a ½ cup of of a high polyphenol food such as blueberries, contains about 325 milligrams of polyphenols, thus even with the higher dose, participants will be receiving an amount of polyphenols that is less than ¼ cup of blueberries. The grape marc powder is prepared in a facility that is certified for producing food-grade products, and the nutritional composition and safety of the product will be thoroughly evaluated before we begin the study. The objective of the current study is to determine if this chardonnay grape marc powder enriched with grape seed extract supplementation has beneficial impacts on the human blood lipid profile and to correlate gut biome changes to human metabolism.
Study Started
Aug 01
2017
Primary Completion
Jun 28
2019
Study Completion
Jun 28
2019
Last Update
Jul 16
2021

Dietary Supplement Chardonnay grape marc marc high polyphenol dose (120mg)

3 prepackaged capsules taken once in the morning with meal for 3 weeks. The total dose will be 120mg of total polyphenols

Dietary Supplement Chardonnay grape marc powder low polyphenol dose (75mg)

3 prepackaged capsules taken once in the morning with meal for 3 weeks. The total dose will be 75mg of total polyphenols

Dietary Supplement Placebo (0mg)

3 prepackaged capsules taken once in the morning with meal for 3 weeks. The total dose will be 0mg of polyphenols

Group 1 Experimental

Order of treatments: A: Chardonnay grape marc powder high polyphenol dose B: Chardonnay grape marc powder low polyphenol dose C: Placebo

Group 2 Experimental

Order of treatments: A: Chardonnay grape marc powder high polyphenol dose C: Placebo B: Chardonnay grape marc powder low polyphenol dose

Group 3 Experimental

Order of treatments: B: Chardonnay grape marc powder low polyphenol dose C: Placebo A: Chardonnay grape marc powder high polyphenol dose

Group 4 Experimental

Order of treatments: B: Chardonnay grape marc powder low polyphenol dose A: Chardonnay grape marc powder high polyphenol dose C: Placebo

Group 5 Experimental

Order of treatments: C: Placebo A: Chardonnay grape marc powder high polyphenol dose B: Chardonnay grape marc powder low polyphenol dose

Group 6 Experimental

Order of treatments: C: Placebo B: Chardonnay grape marc powder low polyphenol dose A: Chardonnay grape marc powder high polyphenol dose

Criteria

Inclusion Criteria:

BMI ≥ 25 and < 40 kg/m2
Dyslipidemia as defined as (any one or all of the following values):
Total cholesterol > 190 mg/dL but < 240 mg/dL
LDL-cholesterol > 130 mg/dL but < 160 mg/dL
HDL-cholesterol < 40 mg/dL (men)/<50 mg/dL (women)
Fasting triglycerides > 150 mg/dL but < 300 mg/dL

Exclusion Criteria:

Renal, cardiovascular, gastrointestinal or hepatic disease, by medical history
History of a previous cardiovascular event
Diagnosis of type 2 diabetes
Pregnancy or lactation
Use of tobacco
Food sensitivities or allergies to the foods or components of foods provided in the standard meals including gluten, dairy, egg, soy, nuts, or seafood
Use of herbal or plant-based supplements; omega-3 fatty acids, and fish oils in the past 3-6 months, and unwilling to discontinue use while participating in the study.
Use of lipid-lowering, glucose-lowering, anti-hypertensive, or weight loss medications
Use of antibiotics in the last three months.
No Results Posted